FR2115363B1 - - Google Patents

Info

Publication number
FR2115363B1
FR2115363B1 FR7142022A FR7142022A FR2115363B1 FR 2115363 B1 FR2115363 B1 FR 2115363B1 FR 7142022 A FR7142022 A FR 7142022A FR 7142022 A FR7142022 A FR 7142022A FR 2115363 B1 FR2115363 B1 FR 2115363B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7142022A
Other versions
FR2115363A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Smith Kline and French Laboratories Ltd
GlaxoSmithKline LLC
Original Assignee
Smith Kline and French Laboratories Ltd
GlaxoSmithKline LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline and French Laboratories Ltd, GlaxoSmithKline LLC filed Critical Smith Kline and French Laboratories Ltd
Publication of FR2115363A1 publication Critical patent/FR2115363A1/fr
Application granted granted Critical
Publication of FR2115363B1 publication Critical patent/FR2115363B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
FR7142022A 1970-11-25 1971-11-24 Expired FR2115363B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9286070A 1970-11-25 1970-11-25

Publications (2)

Publication Number Publication Date
FR2115363A1 FR2115363A1 (fr) 1972-07-07
FR2115363B1 true FR2115363B1 (fr) 1975-06-13

Family

ID=22235517

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7142022A Expired FR2115363B1 (fr) 1970-11-25 1971-11-24

Country Status (11)

Country Link
US (1) US3701775A (fr)
AU (1) AU452852B2 (fr)
BE (1) BE775458A (fr)
CA (1) CA960662A (fr)
CH (1) CH567515A5 (fr)
DE (1) DE2158330A1 (fr)
ES (1) ES397308A1 (fr)
FR (1) FR2115363B1 (fr)
GB (1) GB1327510A (fr)
NL (1) NL7116207A (fr)
ZA (1) ZA717133B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4000133A (en) * 1973-06-06 1976-12-28 Fujisawa Pharmaceutical Co., Ltd. Substituted 7-styryl-carbonyloxy-acetamido cephalosporanic
GB1476981A (en) * 1974-06-05 1977-06-16 Bristol Myers Co Substituted penicillanic acids
US4085277A (en) * 1975-01-30 1978-04-18 Fujisawa Pharmaceutical Co., Ltd. 7(2-Phenyl or thienyl-2-isonicotinoyloxyacetamido)-3-(1-methyl-1-H tetrazol-5-yl)thiomethyl-3-cephem-4-carboxylic acid
US4112228A (en) * 1976-07-13 1978-09-05 Bristol-Myers Company 7-(D-α-Hydroxy-2-arylacetamido)-3-(2-carboxyalkyl-2,3-dihydro-s-triazolo-[4,3-b]pyridazin-3-on-6-ylthiomethyl)-3-cephem-4-carboxylic acids and derivatives
US4236002A (en) * 1977-12-23 1980-11-25 Yeda Research & Development Co., Ltd. Cephalosporin derivatives
WO1984001949A1 (fr) * 1982-11-10 1984-05-24 Kyoto Pharma Ind Derives de cephalosporine, leur procede de preparation et agent prophylactique de traitement contre les infections bacteriennes
DK401088A (da) * 1987-07-21 1989-01-22 Kyoto Pharma Ind Cephalosporinforbindelse, fremgangsmaade til fremstilling deraf og farmaceutisk praeparat indeholdende den
AU2013331880B2 (en) * 2012-10-19 2018-08-09 Sandoz Ag Novel process for preparing ceftaroline fosamil

Also Published As

Publication number Publication date
DE2158330A1 (de) 1972-06-08
CA960662A (en) 1975-01-07
GB1327510A (en) 1973-08-22
AU452852B2 (en) 1974-08-28
FR2115363A1 (fr) 1972-07-07
NL7116207A (fr) 1972-05-29
AU3612671A (en) 1973-05-31
US3701775A (en) 1972-10-31
BE775458A (fr) 1972-05-17
CH567515A5 (fr) 1975-10-15
ZA717133B (en) 1972-07-26
ES397308A1 (es) 1974-05-16

Similar Documents

Publication Publication Date Title
AR204384A1 (fr)
FR2115363B1 (fr)
ATA96471A (fr)
AU465421B2 (fr)
AU2044470A (fr)
AU1473870A (fr)
AU1326870A (fr)
AU1336970A (fr)
AU2017870A (fr)
AU1833270A (fr)
AU2085370A (fr)
AU1517670A (fr)
AU1716970A (fr)
AR195465A1 (fr)
AU1789870A (fr)
AU1969370A (fr)
AU1004470A (fr)
AU2144270A (fr)
AU1974970A (fr)
AU1591370A (fr)
AU1832970A (fr)
AU2112570A (fr)
AU1841070A (fr)
AU1943370A (fr)
AU1881070A (fr)

Legal Events

Date Code Title Description
ST Notification of lapse